Resmed (RSMDF) EPS (Diluted) Growth (5y) (2014 - 2026)
Powered by 
Analysis
Resmed (RSMDF) EPS (Diluted) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.53% |
| Mar 31, 2026 | 47.89% |
| Dec 31, 2025 | 16.95% |
| Sep 30, 2025 | 14.21% |
| Jun 30, 2025 | 16.11% |
| Mar 31, 2025 | 17.23% |
| Dec 31, 2024 | 16.20% |
| Sep 30, 2024 | 20.57% |
| Jun 30, 2024 | 39.73% |
| Mar 31, 2024 | 22.78% |
| Dec 31, 2023 | 10.39% |
| Sep 30, 2023 | 15.17% |
| Jun 30, 2023 | 15.35% |
| Mar 31, 2023 | 15.58% |
| Dec 31, 2022 | 87.28% |
| Sep 30, 2022 | 18.97% |
| Jun 30, 2022 | 38.94% |
| Mar 31, 2022 | 14.63% |
| Dec 31, 2021 | 20.50% |
| Sep 30, 2021 | 20.95% |